DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

MRI Homepage

Researchers develop MR technique to predict and prevent pregnancy complications Tracking water molecules to assess placenta health

Community practices not abiding by breast cancer screening guidelines for MR High breast density isn't enough

Mayo Clinic expert emphasizes safety demands of interventional MR procedures Ideal solution is a dedicated iMR site

Sectra announces MR and ultrasound monitoring capabilities for DoseTrack Will no longer be limited to information from ionizing sources

Top 10 trends and takeaways from RSNA 2017 Are radiologists going the way of the dodo bird? Of course not / Yes, yes they are

Expert makes the case for patient access to radiology reports Patients want a more active role in their care

GE debuts new flexible, blanket-like MR coils at RSNA Improves patient comfort during whole body exams

Siemens unveils its GOKnee3D MR application at RSNA Cuts knee MR exam times in half

Siemens unveils two new intraoperative multi-modality therapy suites at RSNA The nexaris Angio-MR-CT and nexaris Angio-CT

MR machine rented to scan single terrorist at Guantánamo doesn't work Liquid helium dissipated for unknown reasons

MR image of the prostate
Courtesy of Siemens Healthineers

Study finds MR is cost-effective for detecting prostate cancer, guiding biopsies

by Lauren Dubinsky , Senior Reporter
Prostate cancer detection may be on the verge of a paradigm shift.

A new study published in Radiology found that despite the skepticism, MR imaging is cost-effective for detecting the disease and guiding biopsies.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory



"Many consider MRIs to be cost-prohibitive, especially when evaluating for a common entity such as prostate cancer," Dr. Vikas Gulani, study advisor and professor at Case Western Reserve University School of Medicine, said in a statement. "This was our expectation as well, prior to doing this work, but our study found the opposite."

The current standard for detecting prostate cancer involves retrieving 12 biopsy samples during an invasive transrectal ultrasound procedure. Most tumors are not visible on ultrasound images, so up to 40 percent of clinically significant tumors are missed, according to the research.

MR is more expensive, but it does a better job of detecting these clinically significant cancers. It also can reduce the costly burden of overtreatment because it often doesn't spot low-risk cancer.

A research team from Case Western and University Hospitals Cleveland Medical Center used MR to evaluate the study participants for potentially harmful lesions. They used that data and one of three MR-guided strategies to biopsy the potential foci of cancer or bypassed biopsy if the scan was completely negative.

They found that using MR to detect the lesions and guide biopsies increased standardized quality-adjusted life years for patients, and was cost-effective in about 94 percent of the simulations. The results were consistent across all age groups.

The researchers believe that these findings could help to streamline prostate cancer treatment protocols and reduce overall costs. The costs are rising and expensive; inefficient diagnostic pathways and placing patients in the wrong treatment groups are partially to blame, according to Gulani.

"If we can maximize efficiency in how we identify clinically significant lesions and diagnose patients, we can reduce unnecessary treatments for our patients, and reduce costs to our hospitals," he added.

The Barbara Ann Karmanos Cancer Institute in Detroit announced last month that it's using a combination of 3-D MR and live ultrasound to target prostate biopsies. Their UroNav Fusion Biopsy System fuses the MR and ultrasound images.

"Previously, we used ultrasound alone for biopsies," Dr. Michael Cher, professor at the institute, said in a statement. "Now, with the fusion of the MRI and ultrasound images, we perform targeted biopsies of suspicious areas. We are better at finding cancers, and therefore better at determining the best treatment plan for each patient."

Back to HCB News
  Pages: 1

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED